Praise for Harriet A. Washington'sDeadly Monopolies
Important. . . . Humane. . . . An extraordinary achievement. . . . Deadly Monopolies explores contentious issues in modern biomedical research that have been aggravated by the field s commercial emphasis. . . . Washington offers an overarching framework that enables readers to see connections that are often obscured. The book s brilliance lies in the compassionately told narratives of individuals whose lives have been affected by the increasing corporate control of scientific research.
The American Prospect
Harriet Washington shines her relentless torch into the darkest corners of Big Pharma with courage, dedication and accuracy.
John le Carre
Harriet Washington has written an important and compelling book. She shows how recent changes in patent law have caused drug prices to soar, while reducing innovation by drug companies to near-zero. Well-documented, yet highly readable, the book paints a vivid picture of an industry that now exploits monopoly rights to patients genes, and relies on taxpayer-funded NIH research for its few novel and important drugs even as it turns out an endless stream of trivial variations of top-selling old drugs.
Marcia Angell, M.D., author of The Truth About the Drug Companies and former editor of the New England Journal of Medicine
Big Pharma is not going to like Deadly Monopolies one bit, but you probably will especially if, like most Americans, you re finding the co-pay on your drugs too much to handle. Washington correctly reminds us that, as hard as high drug costs are in the USA, they are lethal for the world s poor. Brava Harriet Washington!
Laurie Garrett, Pulitzer Prize-winning writer and author of I Heard the Sirens Scream: How Americans Responded to the 9/11 and Anthrax Attacks
Patents, we re repeatedly told, are crucial to fostering innovation. Deadly Monopolies reveals how the privatization of medical science is retarding research, putting patients at risk, and making what cures we have exorbitantly expensive. This book is a meticulously documented expose of what s gone wrong with our medical innovation system, and a roadmap for change.
Merrill Goozner, author of The $800 Million Pill: The Truth Behind The Cost of New Drugs
[Washington] adeptly details the wide-ranging repercussions ofthis monopolistic research model andrecounts chilling anecdotes that reveal a pattern of shady practices by biotech and pharma companies. . . . The author clearly presents data to elucidate these complexissues, and cogently argues that there are opportunities to reinstate transparency, collaboration and altruism in drug development and disbursement. A gripping, revelatory account.
Kirkus Reviews (starred review)